OBJECTIVE: To determine the prevalence of Pseudomonas aeruginosa colonization on intensive care unit (ICU) admission, risk factors for P. aeruginosa colonization, and the incidence of subsequent clinical culture with P. aeruginosa among those colonized and not colonized. METHODS: We conducted a cohort study of patients admitted to a medical or surgical intensive care unit of a tertiary care hospital. Patients had admission perirectal surveillance cultures performed. Risk factors analyzed included comorbidities at admission, age, sex, antibiotics received during current hospitalization before ICU admission, and type of ICU. RESULTS: Of 1,840 patients, 213 (11.6%) were colonized with P. aeruginosa on ICU admission. Significant risk factors in the multivariable analysis for colonization were age (odds ratio, 1.02 [95% CI, 1.01-1.03]), anemia (1.90 [1.05-3.42]), and neurologic disorder (1.80 [1.27-2.54]). Of the 213 patients colonized with P. aeruginosa on admission, 41 (19.2%) had a subsequent clinical culture positive for P. aeruginosa on ICU admission and 60 (28.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization (ICU period and post-ICU period). Of these 60 patients, 49 (81.7%) had clinical infections. Of the 1,627 patients not colonized on admission, only 68 (4.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization. Patients colonized with P. aeruginosa were more likely to have a subsequent positive clinical culture than patients not colonized (incidence rate ratio, 6.74 [95% CI, 4.91-9.25]). CONCLUSIONS: Prediction rules or rapid diagnostic testing will help clinicians more appropriately choose empirical antibiotic therapy for subsequent infections.
OBJECTIVE: To determine the prevalence of Pseudomonas aeruginosa colonization on intensive care unit (ICU) admission, risk factors for P. aeruginosa colonization, and the incidence of subsequent clinical culture with P. aeruginosa among those colonized and not colonized. METHODS: We conducted a cohort study of patients admitted to a medical or surgical intensive care unit of a tertiary care hospital. Patients had admission perirectal surveillance cultures performed. Risk factors analyzed included comorbidities at admission, age, sex, antibiotics received during current hospitalization before ICU admission, and type of ICU. RESULTS: Of 1,840 patients, 213 (11.6%) were colonized with P. aeruginosa on ICU admission. Significant risk factors in the multivariable analysis for colonization were age (odds ratio, 1.02 [95% CI, 1.01-1.03]), anemia (1.90 [1.05-3.42]), and neurologic disorder (1.80 [1.27-2.54]). Of the 213 patients colonized with P. aeruginosa on admission, 41 (19.2%) had a subsequent clinical culture positive for P. aeruginosa on ICU admission and 60 (28.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization (ICU period and post-ICU period). Of these 60 patients, 49 (81.7%) had clinical infections. Of the 1,627 patients not colonized on admission, only 68 (4.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization. Patients colonized with P. aeruginosa were more likely to have a subsequent positive clinical culture than patients not colonized (incidence rate ratio, 6.74 [95% CI, 4.91-9.25]). CONCLUSIONS: Prediction rules or rapid diagnostic testing will help clinicians more appropriately choose empirical antibiotic therapy for subsequent infections.
Authors: Heather P Green; Judith A Johnson; Jon P Furuno; Sandra M Strauss; Eli N Perencevich; Ebbing Lautenbach; Dong Lee; Anthony D Harris Journal: Infect Control Hosp Epidemiol Date: 2007-05-31 Impact factor: 3.254
Authors: Anthony D Harris; Brandon Fleming; Jonathan S Bromberg; Peter Rock; Grace Nkonge; Michele Emerick; Michelle Harris-Williams; Kerri A Thom Journal: Infect Control Hosp Epidemiol Date: 2015-04 Impact factor: 3.254
Authors: J A Sidler; R Frei; S Tschudin-Sutter; M Dangel; M Battegay; M Weisser; J Passweg; A F Widmer Journal: Clin Microbiol Infect Date: 2015-02-10 Impact factor: 8.067
Authors: Anthony D Harris; J Kristie Johnson; Kerri A Thom; Daniel J Morgan; Jessina C McGregor; Adebola O Ajao; Anita C Moore; Angela C Comer; Jon P Furuno Journal: Infect Control Hosp Epidemiol Date: 2011-07 Impact factor: 3.254
Authors: M Thuong; K Arvaniti; R Ruimy; P de la Salmonière; A Scanvic-Hameg; J C Lucet; B Régnier Journal: J Hosp Infect Date: 2003-04 Impact factor: 3.926
Authors: L Nesher; K V I Rolston; D P Shah; J T Tarrand; V Mulanovich; E J Ariza-Heredia; R F Chemaly Journal: Transpl Infect Dis Date: 2014-12-27 Impact factor: 2.228
Authors: Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin Journal: N Engl J Med Date: 2014-03-27 Impact factor: 91.245
Authors: Anthony D Harris; Alyssa N Sbarra; Surbhi Leekha; Sarah S Jackson; J Kristie Johnson; Lisa Pineles; Kerri A Thom Journal: Infect Control Hosp Epidemiol Date: 2018-02-05 Impact factor: 3.254
Authors: Melinda M Pettigrew; Janneane F Gent; Yong Kong; Alison Laufer Halpin; Lisa Pineles; Anthony D Harris; J Kristie Johnson Journal: Clin Infect Dis Date: 2019-08-01 Impact factor: 9.079
Authors: Stephanie M Cabral; Katherine E Goodman; Natalia Blanco; Surbhi Leekha; Larry S Magder; Gita Nadimpalli; Lisa Pineles; Kerri A Thom; Anthony D Harris Journal: Infect Control Hosp Epidemiol Date: 2020-12-17 Impact factor: 6.520
Authors: Fleur P Paling; Martin Wolkewitz; Pieter Depuydt; Liesbet de Bus; Frangiscos Sifakis; Marc J M Bonten; Jan A J W Kluytmans Journal: Antimicrob Resist Infect Control Date: 2017-04-20 Impact factor: 4.887
Authors: Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240